Namhoon Cho

Namhoon Cho

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Oncogene
Verified
Journal Article
Closed access
MGM-Q Gao
M-Q Gao
YCY-P Choi
Y-P Choi
SKS Kang
S Kang
JYJ H Youn
J H Youn
NCNamhoon Cho
Namhoon Cho

18 September 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
JSJin Sol Sung
Jin Sol Sung
CKChan Woo Kang
Chan Woo Kang
SKSuki Kang
Suki Kang
YJYeonsue Jang
Yeonsue Jang
YCYoung Chan Chae
Young Chan Chae
NCNamhoon Cho
Namhoon Cho

15 October 2010 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
MGMing-Qing Gao
Ming-Qing Gao
BKBaek Gil Kim
Baek Gil Kim
SKSuki Kang
Suki Kang
YCYoon Pyo Choi
Yoon Pyo Choi
HPHangran Park
Hangran Park
NCNamhoon Cho
Namhoon Cho
Fibroblasts were extracted from tissue in tumor burden zones, distal normal zones and interface zones between tumor and normal tissue of human breast carcinomas, and the corresponding fibroblasts were designated as cancer-associated fibroblasts (CAFs), normal zone fibroblasts (NFs) and interface zone fibroblasts (INFs). The crosstalk between three types of fibroblasts and breast cancer cells was evaluated using an in vitro direct co-culture model. We found that INFs grew faster and expressed higher levels of fibroblast activation protein than did NFs and CAFs. Compared with CAFs and NFs, INFs grown with breast cancer cells were significantly more effective in inducing an epithelial-mesenchymal transition (EMT) in cancer cells, as indicated by induction of vimentin and N-cadherin and downregulation of E-cadherin. This EMT process was also accompanied by activation of extracellular signal-regulated kinase (ERK) and modulation of membrane-type 1 matrix metalloproteinase (MT1-MMP) expression. Additionally, INFs promoted breast cell migration to a larger extent compared with NFs and CAFs. Taken together, these findings indicate that INFs isolated from the tumor interface zone exhibited more robust biological modulatory activity than did NFs and CAFs isolated from normal and tumor zones of the same tumor tissue, suggesting that the interface zone of the tumor represents a dynamic region vital to tumor progression.

8 July 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
EPEunhyang Park
Eunhyang Park
SKSang Wun Kim
Sang Wun Kim
SKSunghoon Kim
Sunghoon Kim
HKHyun-Soo Kim
Hyun-Soo Kim
JLJung-Yun Lee
Jung-Yun Lee
NCNamhoon Cho
Namhoon Cho

1 January 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
BKBaek Gil Kim
Baek Gil Kim
HAHee Jung An
Hee Jung An
SKSuki Kang
Suki Kang
YCYoon Pyo Choi
Yoon Pyo Choi
MGMing-Qing Gao
Ming-Qing Gao
NCNamhoon Cho
Namhoon Cho

2 March 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
BKBaek Gil Kim
Baek Gil Kim
MGMing-Qing Gao
Ming-Qing Gao
SKSuki Kang
Suki Kang
YCYoon Pyo Choi
Yoon Pyo Choi
JLJoo Hyun Lee
Joo Hyun Lee
NCNamhoon Cho
Namhoon Cho
Tumor growth generates mechanical compression, which may trigger mechanotransduction in cancer and stromal cells and promote tumor progression. However, very little is known about how compression stimulates signal transduction and contributes to tumor progression. In the present study, we demonstrated that compression enhances a tumor progression phenotype using an in vitro compression model, and validated the results from the in vitro model with high- and low-compressed breast cancer tissues. Mechanical compression induced miR-9 downregulation by DNMT3A-dependent promoter methylation in the MDA-MB-231 and BT-474 breast cancer cell lines and in cancer-associated fibroblasts. The overexpression of miR-9 target genes (LAMC2, ITGA6, and EIF4E) was induced by miR-9 downregulation, which eventually enhanced vascular endothelial growth factors production. Demethylation and decompression could reverse compression-induced miR-9 downregulation and following overexpression of miR-9 target genes and VEGFA.